Search Results 1001-1010 of 18642 for hepatitis

  1. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    Active hepatitis B infection as demonstrated by test for hepatitis B surface antigen. Participants who are hepatitis B surface antigen negative but are ...

  2. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    ... hepatitis B surface antigen positivity, or hepatitis C with measurable viral titer. NOTE: Patients with antibody to hepatitis B core antibody are eligible ...

  3. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    langitis, Portal hypertension, Hemochromatosis, Autoimmune hepatitis, Primary biliary cholangitis, Hepatic encephalopathy. Show more areas of focus for ...

  4. Vancomycin for Primary Sclerosing Cholangitis - Mayo Clinic

    Hepatitis B infection ii. Hepatitis C infection (antibody positive); patients with a history of hepatitis C infection will be eligible for this study if ...

  5. Publications - Jane W. Njeru, M.B., Ch.B. - Mayo Clinic

    Hepatitis B Screening of At-Risk Immigrants Seen at Primary Care ... HIV, hepatitis B and hepatitis C coinfection in Kenya. AIDS. 2008 Jun 19; 22 ...

  6. Living-donor transplant - Doctors & Departments - Mayo Clinic

    ... hepatitis, Autoimmune hepatitis, Amyloidosis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Budd-Chiari syndrome ...

  7. Alumni - Center for Clinical and Translational Science

    D., Hepatitis B and hepatitis C as risk factors for hepatocellular carcinoma in Somali immigrants — Role of viral genetics/epigenetics and the immune ...

  8. Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant - Mayo Clinic

    ... hepatitis B surface antigen [anti-HBs]) must be screened using real-time polymerase chain reaction (PCR) measurement of hepatitis B virus (HBV) DNA levels.

  9. Surgery - Doctors - Mayo Clinic

    nt, Living donor kidney transplant, Cirrhosis, Liver cancer, Alcoholic hepatitis, Autoimmune hepatitis, Acute liver failure, Kidney failure, Fatty liver disease ...

  10. Inebilizumab-cdon (intravenous route) - Side effects & uses - Mayo Clinic

    Hepatitis B infection, active or; Tuberculosis, active or untreated inactive (latent)—Should not be given to patients with these conditions. Infection—Use ...